Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced 6-step preparation method for CDK4/6 inhibitor SHR6390. Delivers high purity, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN110590760B reveals a novel one-pot synthesis for anticancer intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel water-based hydrogenation method reduces costs and simplifies purification for high-purity tetrahydroquinoxaline pharmaceutical intermediates.
Patent CN115286609B reveals efficient ruthenium-catalyzed route. Enables high-purity pharmaceutical intermediates with reduced operational risks and scalable production capabilities.
Patent CN114195711B details a novel one-step carbonylation for quinoline-4(1H)-one. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering safer CO sources and high yields for pharmaceutical intermediates.
Novel copper-catalyzed one-pot method for 2,3-disubstituted indolines. Reduces steps, enhances purity, ensures supply chain reliability for pharmaceutical manufacturing.
Patent CN110577457A enables efficient aryl carboxylic acid synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN102060779A details a copper-catalyzed route for 2-aminobenzimidazoles. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN109776546B details a high-yield Re-catalyzed synthesis of indolopyrrolones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN113896648B reveals nickel-catalyzed synthesis reducing toxic gas reliance and enhancing supply chain stability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones. High yield, broad substrate scope, cost-effective API intermediate manufacturing.
Novel isonitrile-based route for quinoline derivatives. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iodine-catalyzed reduction method offers high purity intermediates with significant cost and supply chain advantages for pharmaceutical manufacturing processes globally.
Novel Cu(I)-catalyzed cyclization for 2,3-disubstituted indoles. High yield, mild conditions, cost-effective scale-up for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method offers high yields and substrate compatibility for scalable API intermediate manufacturing.
Patent CN115772157B reveals cobalt-catalyzed route for 2-alkoxyindoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.